ACADIA Pharmaceuticals Inc. - Common Stock (NQ:ACAD)

28.53 +1.38 (+5.08%)

Streaming Delayed Price Updated: 9:46 AM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ACADIA Pharmaceuticals Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Emergent ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 27, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

May 26, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

May 12, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Earnings Scheduled For May 5, 2021 ↗

May 05, 2021

Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Stocks Drop On May 5 As Inflation Rises And Growth Slows ↗

May 05, 2021

Stocks finished mostly lower, with the S&P 500 up just 7 bps, while the Qs fell by almost 35 bps. The index had been higher nearly all day and fell sharply going into the final hour of trading.

Via Talk Markets

Topics Stocks

Acadia Pharmaceuticals Reports First Quarter 2021 Financial Results

May 05, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

NASDAQ:ACAD Investor Notice: Lawsuit Alleges Misleading Statements by ACADIA Pharmaceuticals Inc ↗

May 04, 2021

San Diego, CA -- (SBWIRE) -- 05/04/2021 -- An investor, who purchased NASDAQ:ACAD shares, filed a lawsuit against ACADIA Pharmaceuticals Inc over alleged Securities Laws violations.

Via SBWire

Topics Lawsuit

Acadia Pharmaceuticals to Present at Upcoming Investor Conferences

May 04, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

SHAREHOLDER ALERT: Law Offices of Timothy L. Miles Is Investigating Acadia Pharmaceuticals Inc. on Behalf of Investors

May 02, 2021

SHAREHOLDER ALERT: The Law Offices of Timothy L. Miles Is Investigating Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders

Via EIN Presswire

Topics Lawsuit

The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗

May 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Cramer Gives His Opinion On Lemonade, Pinterest And More ↗

May 02, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he still likes Lemonade Inc (NYSE: LMND). Investors will have to wait a long time for the value of the stock...

Via Benzinga

Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates ↗

May 01, 2021

Following a mixed month in April, the Food and Drug Administration sets out to review another slate of drugs in May. ACADIA Pharmaceuticals Inc.'s (NASDAQ: ACAD) Nuplazid...

Via Benzinga

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

April 30, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

ACAD Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds ACADIA Pharmaceuticals Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm

April 29, 2021

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

INVESTOR ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

April 28, 2021

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Acadia Pharmaceuticals Inc. (ACAD)

April 28, 2021

From Law Offices of Howard G. Smith

Via Business Wire

EQUITY ALERT: ROSEN, A LEADING LAW FIRM, Encourages Acadia Pharmaceuticals Inc. Investors with Losses to Secure Counsel Before Important Deadline – ACAD

April 27, 2021

From Rosen Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors

April 27, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors

April 26, 2021

From Glancy Prongay & Murray LLP

Via Business Wire

Shareholder Alert: Robbins LLP Is Investigating Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Shareholders

April 23, 2021

From Robbins LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Acadia Pharmaceuticals Inc. (ACAD) Investors

April 23, 2021

From Law Offices of Howard G. Smith

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

April 23, 2021

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ACADIA Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

April 22, 2021

From The Schall Law Firm

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Investors

April 22, 2021

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Acadia Pharmaceuticals Inc. (ACAD) on Behalf of Investors

April 21, 2021

From Law Offices of Howard G. Smith

Via Business Wire

Acadia Pharmaceuticals to Announce First Quarter 2021 Financial Results on May 5, 2021

April 21, 2021

From Acadia Pharmaceuticals Inc.

Via Business Wire

ACADIA PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Acadia Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

April 20, 2021

From Bragar Eagel & Squire, P.C.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 20, 2021

Gainers Artelo Biosciences (NASDAQ:ARTL) stock rose 5.26% to $1.2 during Tuesday's after-market session. This security traded at a volume of 43.6K shares come close, making up...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.